Justin A Renz
CIK 1466562 · CFO · last filed 2026-03-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.51M
Companies
4
Total Filings
45
Lifetime Open-Market Net
-$1.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | CFO | — | $12.65 | — | $0 | 1 | 2026-03-19 |
| ARDX | Chief Financial Officer | 409,052 | $5.69 | $2.33M | -$1.80M | 30 | 2025-08-25 |
| KPTI | EVP, CFO & Treasurer | 19,173 | $9.50 | $182.1K | $113.0K | 8 | 2017-01-24 |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | SVP & CFO | — | — | — | $0 | 2 | 2010-01-20 |
Recent Filings · Page 5 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-01-07 | — | Grant (A) | — | $0 | |
| 2012-01-27 | — | Grant (A) | — | $0 | |
| 2011-02-10 | — | Grant (A) | — | $0 | |
| 2010-01-20 | EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-22 | EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Mixed | — | $0 | EDGAR |
Showing 41–45 of 45
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.